Ensysce Biosciences Management
Management criteria checks 4/4
Ensysce Biosciences' CEO is D. Kirkpatrick, appointed in Jan 2009, has a tenure of 15.33 years. total yearly compensation is $508.58K, comprised of 79.6% salary and 20.4% bonuses, including company stock and options. directly owns 0.021% of the company’s shares, worth $892.76. The average tenure of the management team and the board of directors is 4.4 years and 3.8 years respectively.
Key information
D. Kirkpatrick
Chief executive officer
US$508.6k
Total compensation
| CEO salary percentage | 79.6% |
| CEO tenure | 15.3yrs |
| CEO ownership | 0.02% |
| Management average tenure | 4.4yrs |
| Board average tenure | 3.8yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$509k | US$405k | -US$11m |
| Sep 30 2023 | n/a | n/a | -US$13m |
| Jun 30 2023 | n/a | n/a | -US$20m |
| Mar 31 2023 | n/a | n/a | -US$26m |
| Dec 31 2022 | US$623k | US$393k | -US$25m |
| Sep 30 2022 | n/a | n/a | -US$30m |
| Jun 30 2022 | n/a | n/a | -US$38m |
| Mar 31 2022 | n/a | n/a | -US$31m |
| Dec 31 2021 | US$288k | US$174k | -US$30m |
| Sep 30 2021 | n/a | n/a | -US$19m |
| Jun 30 2021 | n/a | n/a | -US$99k |
| Mar 31 2021 | n/a | n/a | US$172k |
| Dec 31 2020 | US$156k | US$156k | US$57k |
Compensation vs Market: D.'s total compensation ($USD508.58K) is about average for companies of similar size in the US market ($USD663.90K).
Compensation vs Earnings: D.'s compensation has been consistent with company performance over the past year.
CEO
D. Kirkpatrick (66 yo)
15.3yrs
Tenure
US$508,575
Compensation
Dr. D. Lynn Kirkpatrick, Ph.D. is a Co Founder of ProlX Pharmaceuticals Corporation and has been its Chief Executive Officer since 1999. She has been Chief Executive Officer of Ensysce Biosciences, Inc. si...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 15.3yrs | US$508.58k | 0.021% $ 892.8 | |
| CFO, Secretary & Treasurer | 3.3yrs | US$441.95k | 0.0027% $ 116.6 | |
| Chief Commercial Officer | 5.6yrs | US$392.35k | 0% $ 0 | |
| Chief Operating Officer | less than a year | no data | no data | |
| Chairman of Clinical Advisory Board & Chief Medical Officer | 8.3yrs | no data | no data | |
| Chief Development Officer | 2.6yrs | no data | 0% $ 0 |
4.4yrs
Average Tenure
57yo
Average Age
Experienced Management: ENSC's management team is considered experienced (4.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 7yrs | US$508.58k | 0.021% $ 892.8 | |
| Chairman of Clinical Advisory Board & Chief Medical Officer | 1.7yrs | no data | no data | |
| Independent Chairman of the Board | 16.3yrs | US$47.60k | 1.61% $ 68.4k | |
| Independent Director | 2.3yrs | US$29.17k | 0% $ 0 | |
| Independent Director | 4.4yrs | US$30.10k | 0.26% $ 11.2k | |
| Member of the Clinical Advisory Board | no data | no data | no data | |
| Independent Director | 3.8yrs | US$32.92k | 0% $ 0 | |
| Member of the Clinical Advisory Board | no data | no data | no data | |
| Independent Director | 8.3yrs | US$30.10k | 0.41% $ 17.5k | |
| Member of the Clinical Advisory Board | no data | no data | no data | |
| Independent Director | 2.9yrs | US$25.42k | 0% $ 0 | |
| Independent Director | 2.9yrs | US$27.92k | 0% $ 0 |
3.8yrs
Average Tenure
66.5yo
Average Age
Experienced Board: ENSC's board of directors are considered experienced (3.8 years average tenure).